Reference terms from Wikipedia, the free encyclopedia
 

Delayed sleep phase disorder

Delayed sleep phase disorder (DSPD), more often known as delayed sleep phase syndrome and also as delayed sleep–wake phase disorder, is a chronic dysregulation of a person's circadian rhythm (biological clock), compared to those of the general population and societal norms. The disorder affects the timing of sleep, peak period of alertness, the core body temperature, rhythm, hormonal as well as other daily cycles. People with DSPD generally fall asleep some hours after midnight and have difficulty waking up in the morning. People with DSPD probably have a circadian period significantly longer than 24 hours. Depending on the severity, the symptoms can be managed to a greater or lesser degree, but no cure is known, and research suggests a genetic origin for the disorder.

Affected people often report that while they do not get to sleep until the early morning, they do fall asleep around the same time every day. Unless they have another sleep disorder such as sleep apnea in addition to DSPD, patients can sleep well and have a normal need for sleep. However, they find it very difficult to wake up in time for a typical school or work day. If they are allowed to follow their own schedules, e.g. sleeping from 4:00 am to 1:00 pm, their sleep is improved and they may not experience excessive daytime sleepiness. Attempting to force oneself onto daytime society's schedule with DSPD has been compared to constantly living with jet lag; DSPD has been called "social jet lag".

Researchers in 2017 linked DSPD to at least one genetic mutation. The syndrome usually develops in early childhood or adolescence. An adolescent version may disappear in late adolescence or early adulthood; otherwise, DSPD is a lifelong condition. The best estimate of prevalence among adults is 0.13–0.17% (1 in 600). Prevalence among adolescents is as much as 7–16%.

DSPD was first formally described in 1981 by Elliot D. Weitzman and others at Montefiore Medical Center. It is responsible for 7–13% of patient complaints of chronic insomnia. However, since many doctors are unfamiliar with the condition, it often goes untreated or is treated inappropriately; DSPD is often misdiagnosed as primary insomnia or as a psychiatric condition. DSPD can be treated or helped in some cases by careful daily sleep practices, morning light therapy, evening dark therapy, earlier exercise and meal times, and medications such as aripiprazole, melatonin, and modafinil; melatonin is a natural neurohormone partly responsible for the human body clock. At its most severe and inflexible, DSPD is a disability. A chief difficulty of treating DSPD is in maintaining an earlier schedule after it has been established, as the patient's body has a strong tendency to reset the sleeping schedule to its intrinsic late times. People with DSPD may improve their quality of life by choosing careers that allow late sleeping times, rather than forcing themselves to follow a conventional 9-to-5 work schedule.

 
Note:   The above text is excerpted from the Wikipedia article Delayed sleep phase disorder, which has been released under the GNU Free Documentation License.
 

Check out these latest Nanowerk News:

 

Raman microscopy gets a roadmap for biology and medicine

Bioengineers bridge the gap between spectroscopy developers and biologists through a systematic guide explaining modern Raman imaging technologies, probes, and applications.

Interlocking 3D nano-architecture powers solar desalination for freshwater and irrigation

The material's interlocked, porous structure improves salt resistance, water transport, and vapor generation, enabling stable solar desalination outdoors.

Interface layer drives quantum dot tandem solar cells to record efficiency

Researchers used an ultrathin chlorinated polymer layer to cut charge losses and set efficiency records for all-PbS quantum dot tandem solar cells.

Modular nanorobot targets cancer cells and can be reused for other tasks

Researchers developed a versatile nanorobot with propulsion and payload modules. The two reusable modules autonomously self-assemble and could be used in medicine or industry.

Light color controls a photonic synapse that remembers and forgets

Researchers built a photonic synapse that strengthens or erases memory by light color, using a defect to mimic the brain's balanced learning.

Twisting 2D materials brings quantum light control closer to reality

Researchers show that twisting atom-thin boron nitride layers can tune quantum light emitters, offering new control for quantum technologies.

Open-air synthesis yields atom-precise iridium catalyst

A simple air-based method produces stable 15-atom iridium nanoclusters that outperform commercial catalysts for green hydrogen production.

Molecular simulations reveal why nanodrops spread

Simulations reveal why water nanodrops spread on surfaces: molecular structure at the contact line flips line tension, reshaping nanoscale wetting.

AI system monitors 2D semiconductor manufacturing at the atomic layer

Researchers combined low-temperature plasma processing with machine learning to synthesize and etch 6-inch MoS2 and WS2 wafers and predict film thickness in real time.

Paint it blacker: Carbon nanotube coating could make cars ultra-black

A new ultra-black automotive coating absorbs 99.9% of visible light, creating a deeper black finish that could be used on future luxury cars.